Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Radboud universitair medisch centrum Stichting
Sponsor

Radboud universitair medisch centrum Stichting

The Netherlands Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands

About the sponsor

Radboud universitair medisch centrum Stichting supports research in a broad range of cancer types, including prostate cancer, breast cancer, ovarian cancer, glioblastoma, non-small cell lung cancer, rectal cancer, and renal cell carcinoma. Its portfolio also includes hematologic malignancies such as chronic myeloid leukaemia, myelodysplastic syndromes, and acute myeloid leukemia.

  • Prostate cancer and castration-resistant prostate cancer
  • Thoracic, gastrointestinal, and urologic malignancies
  • Hematologic cancer and cellular immunotherapy
  • PET/CT imaging and tumor-targeted diagnostics

The sponsor’s oncology research also extends to precision imaging and immune-based treatment strategies in both solid tumors and blood cancers.

About Specializations

Radboud universitair medisch centrum Stichting runs clinical trials in conditions such as Drug use disorder, Type 1 diabetes mellitus, Parkinson's disease, Inflammation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

71 clinical trials

Diabetes mellitus

Recruiting

Effect of liraglutide on immune response to pneumococcal polysaccharide vaccine in adults with diabetes

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Liraglutide
  • Sponsor:Radboud universitair medisch centrum Stichting

Inflammatory bowel disease+1

Recruiting

Modafinil for Severe Fatigue in Patients with Quiescent Inflammatory Bowel Disease

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Modafinil
  • Sponsor:Radboud universitair medisch centrum Stichting

Diabetic foot

Recruiting

Evaluating the effect of semaglutide on wound healing in patients with diabetic foot ulcers

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Radboud universitair medisch centrum Stichting

Type 1 diabetes mellitus

Recruiting

Study of Colchicine to Reduce Complications in People with Type 1 Diabetes and High Blood Sugar Variability

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Radboud universitair medisch centrum Stichting

Parkinson's disease

Recruiting

Study of Atomoxetine to Reduce Freezing of Gait in Patients with Parkinson's Disease During OFF-State

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Atomoxetine
  • Sponsor:Radboud universitair medisch centrum Stichting

Post-traumatic stress disorder

Recruiting

Title: Study of Hydrocortisone Treatment to Improve Fear Response in Adults with Post-Traumatic Stress Disorder (PTSD) and Hormonal System Changes

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Hydrocortisone
  • Sponsor:Radboud universitair medisch centrum Stichting

Systemic scleroderma

Recruiting

Study on the Effects and Safety of Rituximab and Sodium Chloride in Patients with Active Systemic Sclerosis

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Radboud universitair medisch centrum Stichting

Weaning failure

Recruiting

Study on Faster Weaning from Ventilators in Critically Ill Patients Using Levosimendan and a Drug Combination

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Biotin
  • Sponsor:Radboud universitair medisch centrum Stichting

Metastatic renal cell carcinoma

Recruiting

Study Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Radboud universitair medisch centrum Stichting

Cluster headache

Recruiting

Study on the Effects of Lysergide for Patients with Chronic Cluster Headache

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Lysergide
  • Sponsor:Radboud universitair medisch centrum Stichting

Parkinson's disease

Recruiting

Study of apomorphine and rifaximin for Parkinson's disease patients with reduced levodopa effectiveness

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Domperidone
  • Sponsor:Radboud universitair medisch centrum Stichting

Central serous chorioretinopathy

Recruiting

Study on the Effects of Prednisolone Acetate and Placebo Eye Drops for Patients with Chronic Central Serous Chorioretinopathy

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dextran 70
  • Sponsor:Radboud universitair medisch centrum Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.